SCHEMBL34467103

SCHEMBL34467103

Cn1c(N)nc2cc(-c3cccnc3)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 1/20 0.52
▸ PIK3CD O00329 1/20 0.51
▸ PIP5K1C O60331 1/20 0.51
▸ PIK3CA P42336 1/20 0.51
▸ PI4KA P42356 1/20 0.51
▸ PI4KB Q9UBF8 1/20 0.51
▸ BACE1 P56817 1/20 0.49
▸ MKNK1 Q9BUB5 2/20 0.47
▸ MKNK2 Q9HBH9 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ PSIP1 O75475 1/20 0.47
▸ AXL P30530 1/20 0.47
▸ CYP11B2 P19099 8/20 0.47
▸ CYP11B1 P15538 7/20 0.47
▸ CYP19A1 P11511 3/20 0.46
▸ CYP17A1 P05093 3/20 0.46
▸ FGFR1 P11362 1/20 0.44
▸ HTR1D P28221 1/20 0.44
▸ QPCT Q16769 1/20 0.43
▸ QPCTL Q9NXS2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25681517 1.00 ALOX5AP (0.52) ALOX5APPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL25681516 0.84 NTRK1 (0.45) ALOX5APPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL25681519 0.82 ALOX5AP (0.47) ALOX5APPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL25682150 0.81 ALOX5AP (0.39) ALOX5APBACE1CYP11B2ALDH1A1
SCHEMBL14097461 0.80 HTR1D (0.57) ALOX5APPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL12051553 0.80 ALOX5AP (0.49) ALOX5APPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL25168404 0.78 ABL1 (0.51) ALOX5APCYP11B2CYP11B1ALDH1A1
SCHEMBL31258632 0.78 ABL1 (0.51) ALOX5APCYP11B2CYP11B1ALDH1A1
SCHEMBL12051554 0.77 ALOX5AP (0.47) ALOX5APPIK3CDPIP5K1CPIK3CAPI4KA
SCHEMBL10176218 0.76 CYP11B2 (0.60) ALOX5APMKNK1MKNK2MEN1PSIP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 ALOX5AP 4763/4885PIK3CD 2161/4885PIP5K1C 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback